Skip to main content

Animations

MJFF Publications

7821 - 7830 of 8715 Results
Title
Year
  • Year
  • 2018
  • 2025
  • 2012
  • 2019
  • 2020
  • 2021
  • 2024
  • 2020
  • 2019
  • 2021
  • Summary Details
    OPEN
    Title: Increased substantia nigra echogenicity in LRRK2 family members without mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27443
    Citation Count: 2
  • Summary Details
    OPEN
    Title: NLX‐112 Randomized Phase 2A Trial: Safety, Tolerability, Anti‐Dyskinetic, and Anti‐Parkinsonian Efficacy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.30175
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Competitive HIF Prolyl Hydroxylase Inhibitors Show Protection against Oxidative Stress by a Mechanism Partially Dependent on Glycolysis
    Journal Name: ISRN Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2013/598587
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic Stimulation
    Journal Name: Research
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.34133/2019/7109535
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Selective metabotropic glutamate receptor 2 positive allosteric modulation alleviates L-DOPA-induced psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172957
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Contribution of neuropsychiatric symptoms in Parkinson’s disease to different domains of caregiver burden
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-021-10443-7
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Clinical and Neuropathological Features Associated With Loss of RAB39B
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: public-domain
    DOI - Digital Object Identifier: 10.1002/mds.27951
    Citation Count: 18
  • Summary Details
    RESTRICTED
    Title: A turn for the worse: Turning performance in Parkinson's disease and Essential tremor
    Journal Name: Clinical Biomechanics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clinbiomech.2019.09.008
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Fine mapping of the HLA locus in Parkinson’s disease in Europeans
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00231-5
    Citation Count: 59
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.